Pharmaffiliates

Itacitinib

Itacitinib (also known as INCB039110) is an investigational oral drug that acts as a selective Janus kinase 1 (JAK1) inhibitor. It is being developed for its anti-inflammatory and immunomodulatory properties, with potential applications in treating autoimmune diseases, inflammatory conditions, and certain cancers. Reference standards of Itacitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Itacitinib
    [catalogue_number] => PA 09 1630000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 553.53
    [form] => C26H23F4N9O
    [cas] => 1334298-90-6
    [pslug] => 1334298-90-6-itacitinib-pa091630000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 09 1630000

Itacitinib


  • Catalogue No.:PA 09 1630000

  • CAS :

    1334298-90-6

  • Molecular Formula : C26H23F4N9O

  • Molecular Weight : 553.53